NCT04718051 is a Phase 4 clinical trial of Shen Pu Yang Gan Wan in Liver Diseases, sponsored by Taipei Medical University WanFang Hospital.

Who is sponsoring NCT04718051?

NCT04718051 is sponsored by Taipei Medical University WanFang Hospital.

What drugs are being tested in NCT04718051?

Interventions in NCT04718051: Shen Pu Yang Gan Wan, Placebo.

What condition does NCT04718051 study?

NCT04718051 studies Liver Diseases.

Is NCT04718051 still recruiting?

NCT04718051 is currently status unknown. Last updated 22 January 2021.

Last reviewed 2021-01-22 · How we verify

NCT04718051

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

S.P.PRO LIVER POWDER is Used to Improve Liver and Metabolic Indexes in People With Non-alcoholic Fatty Liver Disease

Status unknown Phase 4 Last updated 22 January 2021

What this trial tests

Phase 4 trial testing Shen Pu Yang Gan Wan in Liver Diseases in 60 participants. Status unknown.

Timeline

13 January 2021

Primary endpoint
31 December 2021

31 December 2021

Quick facts

Lead sponsor	Taipei Medical University WanFang Hospital
Phase	Phase 4
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	60
Start date	13 January 2021
Primary completion	31 December 2021
Estimated completion	31 December 2021
Sites	1 location across Taiwan

Drugs / interventions tested

Shen Pu Yang Gan Wan — full drug profile →
Placebo

Conditions studied

Liver Diseases — all drugs for Liver Diseases →

Sponsor

Taipei Medical University WanFang Hospital

Who can join

Adults 35 to 75, any sex, with Liver Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

With the Westernization of the diet and insufficient exercise, Taiwan's population of obesity, diabetes, and hyperlipidemia has increased in recent years, and the prevalence of the non-alcoholic fatty liver disease has gradually increased. Although weight loss, dietary adjustments, and certain drug treatments can delay the deterioration of the disease; however, weight loss and dietary adjustment are not easy.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Nutritional supplementation for nonalcohol-related fatty liver disease: a network meta-analysis.
Komolafe O, Buzzetti E, Linden A, Best LM, et al · · 2021 · cited 12× · PMID 34280304 · DOI 10.1002/14651858.cd013157.pub2

Verify or expand the search:

Other recruiting trials for Liver Diseases

Currently open trials in the same condition.

NCT07400289 — Development of a FibroScan Liver Examination Using a Single Probe · NA · recruiting
NCT07150624 — The Treatment of Liver Injury After Liver Resection With Polyene Phosphatidylcholine · Phase 4 · recruiting
NCT06871111 — The Microbiota Augmentation to Reestablish Commensal Organisms (MARCO) Trial · Phase 1 · recruiting
NCT06874296 — Assessing Declined Liver Grafts With Normothermic Machine Perfusion to Reduce Transplant Waiting Time · NA · recruiting
NCT07053488 — CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection · Phase 1, PHASE2 · recruiting

Other Taipei Medical University WanFang Hospital trials

Trials by the same sponsor.

NCT07401017 — The Effects of Rosuvastatin on Running Training Adaptation and Safety · NA · not yet recruiting
NCT07293442 — Pelvic Floor Muscle Exercise for Lower Urinary Tract Symptoms After Surgery for Benign Prostatic Hyperplasia. · NA · recruiting
NCT07150182 — Shared Decision-Making for Families in Critical Dialysis Initiation · NA · not yet recruiting
NCT06834425 — Efficacy of NSAID Peritendinous Injection for Acute Tendinitis · NA · active not recruiting
NCT06862297 — Prospective Study Between Polysomnography (PSG) and Novel Ultrasonic Jaw Tracking Device in Patients with Sleep Apnea · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04718051 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Taipei Medical University WanFang Hospital
Last refreshed: 22 January 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04718051.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing